At Japet, our mission is to unleash human capacities through scientifically validated, useful and concrete solutions. This ambition is reflected in a constant R&D dynamic to design exoskeletons that are ever more efficient and accessible, in particular to fight against arduousness and MSDs at work.
It is in this context that the European Union is supporting the JAPET.W2SKIN project, a new generation of back exoskeletons, which are more compact, lightweight and financially accessible, intended to sustainably improve the health of workers.
This project is co-financed by the ERDF as part of the Hauts-de-France FEDER-FSE+-FTJ 2021-2027 program, for the period July 2024 to June 2026. Find all the information on this project below.

JAPET.W2SKIN Project
Description:Japet Medical is developing a new generation of exoskeletons to prevent back pain at work. Compact, lightweight, and financially accessible, this equipment aims to sustainably improve the comfort and health of workers.
Duration: July 2024 — June 2026
Support: Project co-financed by the European Union (FEDER) as part of the Hauts-de-France FEDER-FSE+-FTJ 2021-2027 program.


For the FEDER FSE+ FTJ and EAFRD, the managing authority is the Hauts-de-France Region. Co-financed by the European Union.